Table 1 Basic Characteristics of Study Participants
| Â | All | With subseq. virol. failure | Without subseq. virol. failure |
|---|---|---|---|
| Â | n = 46 | n = 26 | n = 20 |
Gender (male n) | 27 | 16 | 11 |
Age (years) | 5.6 (0.2;14) | 5.0 (0.67; 13.9) | 6.5 (0.7; 13.8) |
Weight below WHO child reference (n) [33] | 43 | 24 | 19 |
Weight median z-score (range) | −2.0 (−4; 0) | −2.5 (−4; 0) | −1 (−4; 1) |
Baseline viral load (RNA/ml) | 1.7e5 (2.1e3;1.2e6) | 2.1e5 (2.4e4; 1.1e6) | 8.4e5 (2.1e3; 1.2e6) |
CD4 count (cells/μL) | 232 (1; 1519) | 154 (1; 1591) | 381 (2; 870) |
Tubercoulosis coinfection (n) | 8 | 3 | 5 |
Clinical CDC stage | Â | Â | Â |
N (not symptomatic) | 7 | 5 | 2 |
A (mildly symptomatic) | 4 | 3 | 1 |
B (moderately symptomatic) | 15 | 7 | 8 |
C (severely symptomatic) | 20 | 11 | 9 |
Immunological CDC stage | Â | Â | Â |
1 | 4 | 1 | 3 |
2 | 11 | 1 | 10 |
3 | 31 | 24 | 7 |